Clinical Trial Update: Troglitazone in Treating Patients With Liposarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying troglitazone for liposarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma

Drugs mentioned

• Troglitazone (troglitazone)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Sarcoma | Phase 2 | Status: COMPLETED